NL
NL · NL · NL-f37e49391504
Opdualag 80 mg/240 mg, concentraat voor oplossing voor infusie
ATC L01FY02
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG
CountryNL (NL)
ATC codeL01FY02
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/22/1679
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/opdualag-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Nivolumab and relatlimab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128943",
"excipients": [
"HISTIDINE, (L-)",
"HISTIDINEMONOHYDROCHLORIDE 1-WATER (L-)",
"PENTETINEZUUR",
"POLYSORBAAT 80 (E 433)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"NIVOLUMAB",
"RELATLIMAB"
],
"leaflet_url": null,
"authorised_at": "2022/09/15",
"procedure_number": "EMEA/H/C/005481",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1679",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code L01FY02.
- PLOpdualagBristol-Myers Squibb Pharma EEIG
- 🇨🇭OpdualagBristol-Myers Squibb SA
- DKOpdualagBristol-Myers Squibb Pharma EEIG
- ISOpdualagBristol-Myers Squibb Pharma EEIG*
- NOOpdualagBristol-Myers Squibb Pharma EEIG (1)
- FIOpdualagBristol-Myers Squibb Pharma EEIG
- CZOPDUALAGBristol-Myers Squibb Pharma EEIG, Dublin
- CAOPDUALAGBRISTOL-MYERS SQUIBB CANADA
Access this data programmatically
Query Opdualag 80 mg/240 mg, concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.